Bray Capital Advisors Organon & Co. Transaction History

Bray Capital Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $60 - $78	-2 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$28.67 - $37.13 $23,624 - $30,595	-824 Reduced 99.76%	2 $0
Q3 2021 Oct 28, 2021	SELL	$28.63 - $35.64 $56,887 - $70,816	-1,987 Reduced 70.64%	826 $27,000
Q2 2021 Jul 28, 2021	BUY	$28.45 - $38.0 $80,029 - $106,894	2,813 New	2,813 $85,000

776

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.54B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Bray Capital Advisors with notifications on news.